AngioDynamics Expects FY2025 Adjusted EPS Loss Of $(0.38)-$(0.42) Versus Consensus Of $(0.41)
Portfolio Pulse from Benzinga Newsdesk
AngioDynamics has announced its expectation for the fiscal year 2025 adjusted EPS to be between $(0.38) and $(0.42), which is in line with the consensus estimate of $(0.41).
October 03, 2024 | 10:39 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
AngioDynamics expects its FY2025 adjusted EPS to be between $(0.38) and $(0.42), aligning with the consensus estimate of $(0.41).
The announcement of the expected EPS loss range aligns with the consensus estimate, suggesting that the market has already priced in this information. Therefore, the short-term impact on the stock price is likely neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100